Kamada (KMDA) Depreciation & Amortization (CF) (2018 - 2024)

Kamada (KMDA) reported Depreciation & Amortization (CF) of $3.2 million for Q3 2024, up 1.98% on a YoY basis from $3.2 million in Q4 2023, and up 1.06% quarter-over-quarter from $3.2 million in Q4 2023.

Kamada (KMDA) Depreciation & Amortization (CF) (2018 - 2024) Analysis & Trends

Kamada has reported Depreciation & Amortization (CF) for 4 years, with the latest figure at $3.2 million in Q3 2024.

  • For the quarter ending Q3 2024, Depreciation & Amortization (CF) rose 1.98% year-over-year to $3.2 million; the trailing twelve-month figure through Jun 2025 stood at $3.2 million (down 49.24% YoY), and the FY2025 full-year result was $1.6 million, up 9.85% from the prior year.
  • Depreciation & Amortization (CF) for Q3 2024 stood at $3.2 million, up from $3.2 million in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $3.2 million in Q3 2024, with the low at $3.2 million in Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Teva Pharmaceutical Industries 39.97 Bn 36.23 Bn 1.97 Bn 239.00 Mn
2 Zoetis 33.59 Bn 31.65 Bn 1.62 Bn 119.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 22.60 Mn
4 Neurocrine Biosciences 16.10 Bn 14.78 Bn 800.70 Mn 7.20 Mn
5 Aurora Cannabis 15.56 Bn 15.47 Bn 21.72 Mn -
6 Elanco Animal Health 12.04 Bn 11.61 Bn 785.00 Mn 172.00 Mn
7 Alkermes 7.36 Bn 6.84 Bn -116.06 Mn 19.43 Mn
8 Lantheus Holdings 6.74 Bn 6.24 Bn 230.92 Mn 22.68 Mn
9 Liquidia 6.27 Bn 6.04 Bn 121.79 Mn 497,000.00
10 Kamada 521.50 -73.15 Mn 19.12 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2024 3.24 Mn
Sep 30, 2024 3.24 Mn
Dec 31, 2023 3.21 Mn
Dec 31, 2023 3.21 Mn
Sep 30, 2023 3.18 Mn
Sep 30, 2023 3.18 Mn
Sep 30, 2019 1.13 Mn
Sep 30, 2019 1.13 Mn
Dec 31, 2018 889,000.00
Dec 31, 2018 889,000.00
Sep 30, 2018 874,000.00
Sep 30, 2018 874,000.00